RGEN Repligen Corporation
$175.80▼ -2.43%
Healthcare
Other
After hours
$175.80▲ +0.00%
Oct 27, 4:02 PM ET
Volume 2.11M
Avg Volume (10D) 1.08M
Key Metrics & Fundamentals
Market Cap
$11.16B
P/E Ratio
240.8
Div Yield
0.00%
52W Range
100.99 - 198.87
% vs 50 MA
-0.96%
% vs 200 MA
21.66%
RSI-14
48.4
MACD Histogram
-0.2700
Beta (1Y vs SPY)
1.21
Free Cash Flow
$26.70M
Gross Rev
$204.13M
Gross Profit
$110.04M
EBITDA
$42.08M
COGS
$94.09M
Operating Exp
$91.04M
Operating Income
$19.00M
EBIT
$19.00M
Pretax Income
$14.15M
Net Income
$5.01M
EPS (Diluted)
0.09
Price & Volume History
Loading chart…
Recent News
Repligen (RGEN) Could Be 12% Undervalued As Record Revenue Lifts Guidance
Simply Wall St. · Oct 27, 2026 9:10 PM ET
Record Revenue Outlook Could Be A Game Changer For Repligen (RGEN)
Simply Wall St. · Oct 27, 2026 5:06 PM ET
Repligen (RGEN) Takes $41.2 Million Impairment Charge As Quarterly Profit Turns To Loss
Simply Wall St. · Oct 27, 2026 4:14 PM ET
Repligen Corp (RGEN) Q3 2026 Earnings Call Highlights: Record Revenue, Raised Guidance, and a ...
GuruFocus.com · Oct 27, 2026 3:03 PM ET
Repligen (RGEN) Stock Looks Fairly Valued As Cash Flow Growth Is Priced In
Simply Wall St. · Oct 27, 2026 2:07 PM ET
Repligen Corporation Q3 2026 Earnings Call Summary
Moby · Oct 27, 2026 1:11 PM ET
Repligen (RGEN) Q3 2026 Earnings Call Transcript
Motley Fool · Oct 27, 2026 11:59 AM ET
What Repligen (RGEN) Said on Its Q3 Earnings Call
MarketBeat · Oct 27, 2026 11:05 AM ET
Repligen Q3 Adjusted Earnings, Revenue Rise; 2026 Adjusted EPS Outlook Narrowed
MT Newswires · Oct 27, 2026 8:04 AM ET
Repligen (NASDAQ:RGEN) exceeds Q3 2026 expectations, full-year outlook slightly exceeds expectations
StockStory · Oct 27, 2026 7:44 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See RGEN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.